bcl-2: Role in epithelial differentiation and oncogenesis

Human Pathology

Volumn 27, Issue 2, 1996, Pages 102-110

  Lu, Qi Long ^a   Abel, Paul ^b   Foster, Christopher S ^b   Lalani, El Nasir ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

apoptosis; bcl 2; epithelial differentiation and morphogenesis

Indexed keywords

HORMONE; MESSENGER RNA; ONCOPROTEIN; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIUM CELL; EPITHELIUM TUMOR; GENE EXPRESSION REGULATION; HUMAN; LUNG CARCINOMA; ONCOGENE; PROGNOSIS; PROSTATE CARCINOMA;

EID: 0030070342     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90362-7     Document Type: Article

References (85)

1. Huebner RJ, Todaro GJ: Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A 64:1087-1094, 1969
2. Bishop JM: Cellular oncogenes and retroviruses. Ann Rev Biochem 52:301-354, 1983
3. Oren M: The p53 cellular tumor antigen: Gene structure, expression and protein properties. Biochem Biophys Acta 823:67-78, 1985
4. Lee EY-HP: Tumor suppressor genes: A new era for molecular genetic studies of cancer. Breast Cancer Res Treat 19:3-13, 1991
5. Yunis JJ, Oken MM, Kaplan ME, et al: Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 307:1231-1236, 1982
6. Tsujimoto Y, Finger LR, Yunis J, et al: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14,18) chromosome translocation. Science 226:1097-1099, 1984
7. Bakhshi A, Jensen JP, Goldman P: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906, 1985
8. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A 82:7439-7443, 1985
9. Tsujimoto Y, Gorham J, Cossman J, et al: The t(14;18) chromosome translocation involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393, 1985
10. Ngan BY, Chen-Levy Z, Weiss LM, et al: Expression in nonHodgkin's lymphoma of the bd-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 318:1638-1644, 1988
11. Pezzella F, Tse AGD, Cordell JL, et al: Expression of the bd-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990
12. Zutter M, Hockenbery D, Silverman GA, et al: Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062-1068, 1991
13. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
14. Chen-Levy Z, Cleary ML: Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem 25:4929-4933, 1990
15. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28, 1986
16. Boise LM, Gonzalez-Garcia M, Postema CE, et al: A bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
17. Kozopas KM, Yang T, Buchan HL, et al: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc Natl Acad Sci U S A 90:3516-3520, 1993
18. Lin EY, Orlofsky A, Bergar M, et al: Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979-1988, 1993
19. Fang W, Rivard JJ, Mueller DL, et al: Cloning and molecular characterization of mouse bcl-X in B and T lymphocytes. J Immunol 153:4388-4398, 1994
20. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676, 1994
21. Pearson GR, Luka J, Petti L, et al: Identification of an Epstein-Barr virus early gene encoding a second complement of the restricted early antigen complex. Viology 160:151-161, 1987
22. Neilan J, Lu Z, Afonso C, et al: An African Swine Fever virus gene with similarity to the bd-2 proto-oncogene and the Epstein Barr virus gene BHRF1. J Viol 67:4391-4394, 1993
23. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609-619, 1993
24. Krajewski S, Krajewska M, Shabaik A, et al: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1336, 1994
25. Farrow SN, White JHM, Martinou I, et al: Cloning of bcl-2 homologue by interaction with adenovirus E1B 19K Nature 374:731-733, 1995
26. L and Bcl-2, displaces Bax and promotes cell-death. Cell 80:285-291, 1995
27. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogens. Nature 359:554-556, 1992
28. Bissonnette RP, Echeverri F, Mahboubi A, et al: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554, 1992
29. Deng G, Podack ER: Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci U S A 90:2189-2193, 1993
30. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556, 1980
31. Compton MM: A biochemical hallmark of apoptosis: Internucleosomal degragation of the genome. Cancer Metastasis Rev 11:105-119, 1992
32. 2+ requiring mechanism(s). J Biol Chem 265:17323-17333, 1990
33. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988
34. Tsujimoto Y: Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Nacl Acad Sci U S A 86:1958-1962, 1989
35. Zhong LT, Sarafian T, Kane DJ, et al: bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533-4537, 1993
36. Alnemri ES, Fernendes TF, Haldar S, et al: Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer 52:491-495, 1992
37. Mah SP, Zhong LT, Liu Y, et al: The protooncogene bcl-2 inhibites apoptosis in PC12 cells. J Neurochem 60:1183-1186, 1993
38. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6, 1994
39. Reed JC, Tsujimoto Y, Alpers JD, et al: Regulation of Bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236:1295-1299, 1987
40. McDonnell TJ, Deane N, Platt FM, et al: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88, 1989
41. Lu QL, Poulson R, Wong L, et al: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431-437, 1993
42. Lu PJ, Lu QL, Rughetti A, et al: bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 129:1363-1378, 1995
43. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
44. Jacobson MD, Burne JF, King MP, et al: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-368, 1993
45. Bafy G, Miyashita T, Williamson JR, et al: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511-6519, 1993
46. Lu QL, Hanby AM, Hajibagheri MA, et al: Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 107:363-371, 1994
47. Sentman CL, Shutter JR, Hockenbery D, et al: bcl-2 inhibites multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888, 1991
48. Strasser A, Harris AW, Gory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899, 1991
49. Hockenbery DM, Oltvai ZN, Yin XM, et al: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251, 1993
50. Shimizu S, Eguchi Y, Kosaka H, et al: Prevention of hypoxiainduced cell death by Bcl-2 and Bcl-xL. Nature 374:811-813, 1995
51. Jacobson M, Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816, 1995
52. Lebrun DP, Warnke RA, Clearly ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743-753, 1993
53. Nathan B, Anbazhagan R, Clarkson P, et al: Expression of BCL-2 in the developing human fetal and infant breast. Histopathology 24:73-76, 1994
54. Navack DV, Korsmeyer SJ: Bcl-2 protein expression during murine development. Am J Pathol 145:61-73, 1994
55. Hockenbery DM, Zutter M, Hickey W, et al: BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
56. Rouleau M, Leger J, Tenniswood M: Ductal heterogeneity of cytokeratins, gene expression and cell death in the rate ventral prostate. Mol Endcrinol 4:2003-2013, 1990
57. Kyprianou N, English HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753, 1990
58. Gompel A, Sabourin JC, Martin A, et al: bcl-2 experience in normal endoinetrium during the menstrual cycle. Am J Pathol 144:1135-1142, 1994
59. Sabourin JC, Martin A, Baruch J, et al: bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59:1-6, 1994
60. McCall CA, Cohen JJ: Programmed cell death in terminally differentiating keratinocytes: Role of endogenous endonuclease. J Invest. Dermatol 97:111-114, 1991
61. Lu QL, Elia E, Lucas S, et al: Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35, 1993
62. Colombel M, Symmans F, Gil S, et al: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390-400, 1993
63. Gee JMW, Roberson JFR, Ellis IO, et al: Immunocytochemical localization of Bcl-2 protein in human breast cancer and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59:1-6, 1994
64. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994
65. Bhargava V, Kell DL, van de Rijn M, et al: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-540, 1994
66. Pezzella F, Turley H, Kuzu I, et al: Bcl-2 proto-oncogene in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
67. Lauwers GY, Scott GV, Hendricks J: Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73:2900-2904, 1994
68. Leek RD, Kaklamanis L, Pezzella F, et al: bcl-2 in normal human breast and carcinoma, association with oestrogen receptorpositive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 69:135-139, 1994
69. Rowe M, Peng Pilon M, Huen DS, et al: Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J Virol 68:5602-5612, 1994
70. Finke J, Lange W, Mertelsmann R, et al: Bcl-2 induction is part of the strategy of Epstein-Barr virus. Leuk Lymphoma 12:413-419, 1994
71. Reed JC, Cuddy M, Slabiak T, et al: Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336:259-261, 1988
72. Strasser A, Harris AW, Bath ML, et al: Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331-333, 1990
73. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254-256, 1991
74. Martin JM, Veis D, Korsmeyer SJ, et al: Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol 67:5269-5278, 1993
75. Nunez G, London L, Hockenbery D, et al: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610, 1990
76. Nataraj A, Pathak S, Hopwood V, et al: bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes. Int J Oncology 4:1211-1218, 1994
77. Nakagawa K, Yamamura K, Maeda S, et al: bcl-2 expression in epidermal keratinocytic diseases. Cancer 74:1720-1724, 1994
78. Bronner MP, Culin C, Reed JC, et al: The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146:20-26, 1995
79. Wang Y, Szekely L, Okan I, et al: Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a V-myc-induced T-cell lymphoma line. Oncogene 8:3427-3431, 1993
80. Miyashita T, Krajewski S, Krajewska M, et al: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805, 1994
81. Selvakumaran M, Lin HK, Miyashita T, et al: Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798, 1994
82. Miyashita T, Harigai M, Hanada M, et al: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135, 1994
83. Haldar S, Negrini M, Momie M, et al: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097, 1994
84. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551-555, 1994
85. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992